Jan Vilček

Q: What Schools Are Affiliated With Jan Vilček

Jan Vilček is affiliated with the following schools: Osaka University, Comenius University, New York University

Jan Vilček's AcademicInfluence.com Rankings

Jan Vilček

Biology

#1850

World Rank

#3000

Historical Rank

Immunology

#136

World Rank

#143

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Jan Vilček Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jan T. Vilček is a Slovak-American biomedical scientist, educator, inventor and philanthropist. He is a professor in the department of microbiology at the New York University School of Medicine, and chairman and CEO of The Vilcek Foundation. Vilček received his M.D. degree from Comenius University Medical School in Bratislava in 1957; and his Ph.D. in Virology from the Institute of Virology, Czechoslovak Academy of Sciences, Bratislava, in 1962.

(See a Problem?)

Jan Vilček's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immune response in mice that lack the interferon-gamma receptor. (1993) (1612)
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. (1987) (1368)
Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. (1991) (822)
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. (1993) (712)
Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors (1986) (619)
IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. (1989) (596)
Induction of β 2-interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation (1986) (534)
Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. (1989) (523)
Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. (1982) (439)
Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide (1993) (394)
Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. (1985) (391)
Involvement of the IRF-1 transcription factor in antiviral responses to interferons. (1994) (323)
Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. (1982) (314)
Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. (1997) (304)
A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44 (1992) (298)
Tumor necrosis factor provokes superoxide anion generation from neutrophils. (1986) (298)
Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence (1990) (297)
Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. (1986) (279)
Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways. (1989) (276)
A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1 (1987) (265)
TSG-14, a tumor necrosis factor- and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. (1993) (258)
Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. (1988) (252)
Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. (1988) (250)
Critical role of a common transcription factor, IRF‐1, in the regulation of IFN‐beta and IFN‐inducible genes. (1992) (231)
The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. (1995) (228)
TNF/IL-1-inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha-inhibitor and exerts a strong anti-inflammatory effect in vivo. (1996) (224)
Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. (1983) (221)
Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. (1983) (216)
Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. (1987) (200)
Historical review: Cytokines as therapeutics and targets of therapeutics. (2004) (196)
TSG-6: an IL-1/TNF-inducible protein with anti-inflammatory activity. (1997) (192)
Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. (1992) (185)
Induction of membrane-associated interleukin 1 by tumor necrosis factor in human fibroblasts. (1987) (184)
Activation of p38 Mitogen-Activated Protein Kinase by Sodium Salicylate Leads to Inhibition of Tumor Necrosis Factor-Induced IκBα Phosphorylation and Degradation (1998) (183)
Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical. (1987) (179)
Two antigenically distinct species of human interferon. (1975) (177)
Interrelationships of human interferon-gamma with lymphotoxin and monocyte cytotoxin (1984) (171)
Isolation and characterization of eight tumor necrosis factor-induced gene sequences from human fibroblasts (1990) (155)
Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein (1992) (151)
Long pentraxins: an emerging group of proteins with diverse functions. (1996) (150)
Fifty years of interferon research: aiming at a moving target. (2006) (148)
TSG-6: a TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis. (1993) (143)
Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. (2004) (142)
Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. (1993) (140)
TSG‐14 transgenic mice have improved survival to endotoxemia and to CLP‐induced sepsis (2001) (139)
Inhibition of Glucocorticoid Receptor-mediated Transcriptional Activation by p38 Mitogen-activated Protein (MAP) Kinase* (2004) (133)
Bacterial lipopolysaccharide-induced interferon-gamma production: roles of interleukin 1 and interleukin 2. (1986) (132)
Tumor necrosis factors. Structure, function, and mechanism of action. (1992) (129)
Tumor necrosis factor and interleukin-1 cause a rapid and transient stimulation of c-fos and c-myc mRNA levels in human fibroblasts. (1987) (124)
Specific binding of 125I-human interferon-gamma to high affinity receptors on human fibroblasts. (1982) (123)
Partial purification and characterization of human gamma (immune) interferon. (1981) (118)
Transcriptional inhibition of the interleukin-8 gene by interferon is mediated by the NF-kappa B site (1994) (115)
Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. (1984) (115)
Cell Stress and MKK6b-mediated p38 MAP Kinase Activation Inhibit Tumor Necrosis Factor-induced IκB Phosphorylation and NF-κB Activation* (1999) (113)
Post-Transcriptional Control of Interferon Synthesis (1971) (111)
Generation of nitric oxide and induction of major histocompatibility complex class II antigen in macrophages from mice lacking the interferon gamma receptor. (1993) (111)
TSG-6, an arthritis-associated hyaluronan binding protein, forms a stable complex with the serum protein inter-alpha-inhibitor. (1994) (110)
Induction and decay of human fibroblast interferon mRNA. (1977) (110)
Antibodies to alpha-interferon in a patient with systemic lupus erythematosus. (1982) (105)
Non-apoptotic Signaling Pathways Activated by Soluble Fas Ligand in Serum-starved Human Fibroblasts (2001) (100)
Mitogenic and cytotoxic actions of tumor necrosis factor in BALB/c 3T3 cells. Role of phospholipase activation. (1989) (100)
Stabilization of interferon messenger RNA activity by treatment of cells with metabolic inhibitors and lowering of the incubation temperature. (1973) (98)
Induction of interferon synthesis by synthetic double-stranded polynucleotides (1968) (97)
Inhibitory effects of human leukocyte and fibroblast interferons on normal and chronic myelogenous leukemic granulocytic progenitor cells. (1981) (94)
Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2. (1985) (92)
Inhibition of Tumor Necrosis Factor-induced p42/p44 Mitogen-Activated Protein Kinase Activation by Sodium Salicylate (*) (1996) (92)
Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts. (1987) (92)
Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. (1988) (91)
Interferon Inducers Protect Mice against Plasmodium berghei Malaria (1968) (91)
Molecular weight of human gamma interferon is similar to that of other human interferons. (1982) (89)
Purified human interleukin-2 enhances induction of immune interferon. (1983) (88)
NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor alpha and interleukin-1 (1994) (88)
Characterization of human tumor necrosis factor produced by peripheral blood monocytes and its separation from lymphotoxin (1985) (86)
Human interferon-gamma is internalized and degraded by cultured fibroblasts. (1983) (85)
Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins. (1994) (84)
Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin‐1, and epidermal growth factor in human fibroblasts (1987) (84)
Synthesis of two distinct interferons by human fibroblasts. (1978) (80)
Promoter Structure and Transcriptional Activation of the Murine TSG-14 Gene Encoding a Tumor Necrosis Factor/Interleukin-1-inducible Pentraxin Protein (*) (1995) (79)
Tumor necrosis factor receptors in HeLa cells and their regulation by interferon-gamma. (1986) (78)
Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. (1998) (77)
Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts. (1989) (75)
Novel interferons (2003) (75)
PRODUCTION OF INTERFERON BY NEWBORN AND ADULT MICE INFECTED WITH SINDBIS VIRUS. (1964) (73)
Amelioration of collagen-induced arthritis in DBA/1J mice by recombinant TSG-6, a tumor necrosis factor/interleukin-1-inducible protein. (2000) (72)
Characteristics of human lymphoblastoid (Namalva) interferon. (1978) (72)
Differential Effects of Actinomycin D and Puromycin on the Release of Interferon induced by Double Stranded RNA (1969) (71)
Synthesis of human interferon by Xenopus laevis oocytes: two structural genes for interferons in human cells. (1977) (68)
Differential regulation of TSG‐14 expression in murine fibroblasts and peritoneal macrophages (2000) (67)
Purification of two subspecies of human gamma (immune) interferon. (1982) (66)
Transcriptional regulation of TSG6, a tumor necrosis factor- and interleukin-1-inducible primary response gene coding for a secreted hyaluronan-binding protein. (1993) (62)
Cytolytic activity of interferon‐gamma and its synergism with 5‐fluorouracil (1984) (61)
Exogenous Interferon protects Mice against Plasmodium berghei Malaria (1970) (60)
METABOLIC DETERMINANTS OF THE INDUCTION OF INTERFERON BY A SYNTHETIC DOUBLE‐STRANDED POLYNUCLEOTIDE IN RABBIT KIDNEY CELLS (1970) (59)
Altered molecular species of human interferon produced in the presence of inhibitors of glycosylation. (1977) (59)
Effects of glycosidase treatment on the physicochemical properties and biological activity of human interferon-gamma. (1983) (55)
Le interferon production by human fibroblasts. (1979) (55)
Human interferon production: superinduction by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole (1975) (55)
Stimulation of human gamma interferon production by diterpene esters (1981) (54)
Suppression of human interferon production by inhibitors of glycosylation. (1975) (53)
Inhibition of growth of B16 murine malignant melanoma by exogenous interferon. (1980) (53)
Studies on an interferon from tickborne encephalitis virus-infected cells (IF). III. Antiviral action of IF. (1962) (53)
Interferons: Physicochemical Properties and Control of Cellular Synthesis (1972) (53)
Three molecular weight forms of natural human interferon-gamma revealed by immunoprecipitation with monoclonal antibody. (1984) (52)
Differential effects of type I IFN and IFN-gamma on the binding of tumor necrosis factor to receptors in two human cell lines. (1986) (51)
TSG-6 expression in human articular chondrocytes. Possible implications in joint inflammation and cartilage degradation. (1996) (49)
Mitogenic action of tumor necrosis factor in human fibroblasts: Interaction with epidermal growth factor and platelet‐derived growth factor (1988) (47)
Inhibition of IκB Kinase Activity by Sodium Salicylate in Vitro Does Not Reflect Its Inhibitory Mechanism in Intact Cells* (2000) (47)
Superinduction of interferon with metabolic inhibitors: possible mechanisms and practical applications. (1976) (47)
Cellular binding characteristics of human interferon. (1974) (45)
Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-beta 2, and is inhibited by specific antibodies to IFN-beta. (1988) (45)
Anti-malarial Effect of Interferon Inducers at Different Stages of Development of Plasmodium berghei in the Mouse (1968) (44)
Plasmodium berghei sporozoites are mitogenic for murine T cells, induce interferon, and activate natural killer cells. (1984) (43)
Interferon-beta induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1. (1994) (42)
Monocyte Activation Following Systemic Administration of Granulocyte‐Macrophage Colony‐Stimulating Factor (1994) (42)
Immunological profile of amyotrophic lateral sclerosis patients and their cell-mediated immune responses to viral and CNS antigens. (1982) (40)
CHAPTER 1 – The cytokines: an overview (2003) (39)
Protective effect of interferon inducers on Plasmodium berghei malaria. (1969) (39)
Regulatory Functions of Interferons (1980) (39)
Cell-free synthesis of human interferon. (1975) (38)
Up-regulation of cyclooxygenase-2 expression by TSG-6 protein in macrophage cell line. (2005) (38)
Generation of nitric oxide and clearance of interferon-gamma after BCG infection are impaired in mice that lack the interferon-gamma receptor. (1995) (38)
CCAAT Box Enhancer Binding Protein (C/EBP-) Stimulates B Element-mediated Transcription in Transfected Cells (*) (1996) (37)
Therapeutic trial of interferon-gamma in patients with epidemic Kaposi's sarcoma. (1985) (37)
Lymphokine-mediated activation of human monocytes: neutralization by monoclonal antibody to interferon-gamma. (1984) (37)
Suppression of the Intracellular Growth of Shigella flexneri in Cell Cultures by Interferon Preparations and Polyinosinic-Polycytidylic Acid (1972) (36)
TSG-6 Protein Binding to Glycosaminoglycans (2005) (36)
Boosting p53 with interferon and viruses (2003) (35)
Partial characterization of gamma (immune) interferon mRNA extracted from human lymphocytes. (1981) (35)
Regulation of human interferon production. I. Superinduction by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole. (1976) (35)
Phase Ib Trial of Granulocyte‐Macrophage Colony‐Stimulating Factor Combined with Murine Monoclonal Antibody R24 in Patients with Metastatic Melanoma (1994) (34)
Production ofHigh-Titered Interferon inCultures ofHumanDiploid Cells (1972) (34)
Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids. (1980) (33)
Recent progress in the elucidation of interferon-gamma actions: molecular biology and biological functions. (1994) (33)
Defective gamma-interferon production in peripheral blood leukocytes of patients with acute tuberculosis (1986) (33)
Monoclonal antibodies to human immune interferon and their application for affinity chromatography. (1984) (33)
ROLE OF INTERFERON IN AIDS a (1984) (32)
Mitogenic effect of double‐stranded RNA in human fibroblasts: Role of autogenous interferon (1987) (32)
Studies on an interferon from tick-borne encephalitis virus-infected cells (IF). IV. Comparison of IF with interferon from influenza virus-infected cells. (1962) (31)
Characterization and affinity crosslinking of receptors for tumor necrosis factor on human cells. (1986) (31)
Natural and recombinant Escherichia coli-derived interferon-gamma differ in their reactivity with monoclonal antibody. (1984) (30)
Enhancement of human interferon production by neutral red and chloroquine: analysis of inhibition of protein degradation and macromolecular synthesis (1975) (30)
Tumor necrosis factor-induced downregulation of its receptors in HeLa cells. (1987) (30)
Interleukin-1 can inhibit interferon-beta synthesis and its antiviral action: comparison with tumor necrosis factor. (1988) (29)
Persistent Tumor Necrosis Factor Signaling in Normal Human Fibroblasts Prevents the Complete Resynthesis of IκB-α* (2000) (29)
Control of Interferon Synthesis: Effect of Diethyl-aminoethyl-Dextran on Induction by Polyinosinic-Polycytidylic Acid (1972) (29)
Overexpression of metallothionein confers resistance to the cytotoxic effect of TNF with cadmium in MCF-7 breast carcinoma cells. (1992) (28)
Two molecular weight forms of human 2',5'-oligoadenylate synthetase have different activation requirements. (1986) (28)
Tumor necrosis factor: Receptor binding and mitogenic action in fibroblasts (1987) (28)
An Interferon-like Substance released from Tick-borne Encephalitis Virus-infected Chick Embryo Fibroblast Cells (1960) (27)
Inhibition of interferon secretion by vinblastine (1975) (26)
Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits (1980) (26)
Regulation of metallothionein gene expression by TNF-α and IFN-β in human fibroblasts (1995) (26)
Cloning and expression of a novel variant of human interferon-gamma cDNA. (1985) (25)
Cellular Mechanisms of Interferon Production (1970) (25)
Virological studies in amyotrophic lateral sclerosis (1982) (24)
Effect of primary amines on interferon action. (1982) (24)
Interferon Induction in Rabbit Cells Irradiated with UV Light (1974) (24)
Regulation of human interferon production. II. Inhibition of interferon messenger RNA synthesis by 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole. (1976) (24)
Interferon induction by vesicular stomatitis virus and its role in virus replication (1977) (23)
Distinguishing characteristics of interferon induction with poly(I)-poly(C) and Newcastle disease virus in human cells. (1975) (23)
Lymphokine production by human T cell hybridomas. (1983) (22)
Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. (1987) (22)
IRF1: a deus ex machina in TH1 differentiation (2008) (22)
Stimulation of Interleukin‐6 mRNA Levels by Tumor Necrosis Factor and Interleukin‐1 (1989) (22)
Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line. (1988) (21)
On the mechanism of enhancement of human interferon production by actinomycin D and cycloheximide. (1976) (20)
Mollucum contagiosum virus in adult human skin cultures. An electron microscopic study. (1969) (20)
Influence of the Rate of Cell Growth and Cell Density on Interferon Action in Chick Embryo Cells (1969) (20)
Antibodies to chromosome 21 coded cell surface components block binding of human α interferon but not λ interferon to human cells (1984) (20)
REgulation of human interferon production stimulated with poly(I)-poly(C): correlation between shutoff and hyporesponsiveness to reinduction. (1977) (20)
Action of interferon and its inducers aginst nonviral infectious agents. (1970) (20)
First Demonstration of the Role of TNF in the Pathogenesis of Disease (2008) (19)
Entrapment of human leukocyte interferon in the aqueous interstices of liposomes (1981) (19)
Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice. (1994) (18)
TSG-6, a glycoprotein associated with arthritis, and its ligand hyaluronan exert opposite effects in a murine model of inflammation (2006) (18)
From IFN to TNF: a journey into realms of lore (2009) (18)
Synthesis of alpha and gamma interferons by a human cutaneous lymphoma with helper T-cell phenotype. (1982) (18)
Comparative studies of the biological activities of human tumor necrosis factor and its derivatives. (1987) (18)
Adverse effects of interferon in virus infections, autoimmune diseases and acquired immunodeficiency. (1984) (17)
Activation of the TSG-6 Gene by NF-IL6 Requires Two Adjacent NF-IL6 Binding Sites (*) (1995) (17)
SPONTANEOUS PRODUCTION OF T (TYPE II) INTERFERON BY A MURINE RETICULUM‐CELL SARCOMA * (1980) (16)
Modulation of lymphocyte proliferation and immunoglobulin synthesis by interferon-gamma and "type I" interferons. (1986) (16)
Gamma interferon induction in human thymocytes activated by lectins and B cell lines (1982) (16)
Increased Interferon Production in Human Cells Irradiated with Ultraviolet Light (1974) (16)
Induction of interference and interferon synthesis by non-replicating molluscum contagiosum virus. (1967) (16)
Immune interferon induction by monoclonal antibody specific for human T cells. (1981) (16)
Structure and function of human interferon-gamma. (1984) (15)
Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. II. Rapid production of antibody-enhancing factor, interleukin 2, and immune interferon. (1984) (15)
The molluscum contagiosum virus in chick embryo cell cultures: an electron microscopic study. (1969) (15)
Determination of human T cell activity in response to allogeneic cells and mitogens. An immunochemical assay for gamma-interferon is more sensitive and specific than a proliferation assay. (1986) (15)
Role of interferon in the anti-melanoma effects of poly (I).poly (C) and Newcastle disease virus. (1973) (14)
TNF as a growth factor. (1992) (14)
Pathways of heat shock protein 28 phosphorylation by TNF in human fibroblasts. (1994) (14)
Interferon induction with Newcastle disease virus in FS-4 cells: effect of priming with interferon and of virus inactivating treatments. (1979) (14)
Renal deposition of alpha interferon in systemic lupus erythematosus (1983) (13)
Inhibition of Sindbis Virus Plaque Formation by Extracts of Escherichia coli (1966) (13)
Regulation of metallothionein gene expression by TNF-alpha and IFN-beta in human fibroblasts. (1995) (13)
Activation of Thymocytes and T Cells by Interleukin‐6 a (1989) (13)
Sequential suppression by actinomycin D of interferon production and cellular resistance induced by Poly I:C. (1971) (12)
Induction of HLA class I mRNA by cytokines in human fibroblasts: comparison of TNF, IL-1 and IFN-beta. (1992) (12)
Cytokine and Growth Factor Reviews to be published six times a year (2002) (12)
Membrane-bound intracellular interferon in rabbit kidney cell cultures. (1972) (12)
Interferons and the immune system (1984) (12)
Correlation of physicohemical and antigenic properties of human leukocyte interferon subspecies (2005) (11)
Monoclonal antibodies as structural probes for oligomeric human interferon-gamma. (1985) (11)
Infection of interferontreated cells with eastern equine encephalomyelitis virus and its ribonucleic acid. (1962) (11)
Potentiation of the action of interferon by extracts of Escherichia coli. (1967) (11)
Human T cell hybridomas secreting immune interferon. (1982) (11)
UNRESPONSIVENESS TO THE ACTION OF INTERFERON DEVELOPED IN PERSISTENTLY INFECTED L CELLS. (1963) (11)
Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts. (1979) (11)
Interferon-γ enhances target cell sensitivity to monocyte killing (1986) (11)
The importance of having gamma. (1982) (11)
Studies on an Interferon from Tick-Borne Encephalitis Virus-Infected Cells ( IF ). I. Appearance of IF in Infected Chick Embryo Cell Cultures. (1961) (10)
Blocking of interferon action by a component of normal serum (2005) (10)
Announcement: interferon nomenclature. (1980) (10)
Formation and Properties of Interferon in the Brain of Tick-Borne Encephalitis Virus-Infected Mice. (1963) (10)
The inauguration of Cytokine & Growth Factor Reviews. (1996) (10)
Intracellular location of newly synthesized interferon in human FS-4 cells. (1976) (10)
Mass production and some characteristics of human interferon from diploid cells. (1974) (10)
FORMATION OF INCOMPLETE SENDAI VIRUS IN EMBRYONATED EGGS. (1964) (10)
Ia-restricted interaction of normal lymphoid cells and SJL lymphoma (reticulum cell sarcoma) leading to lymphokine production. III. Relative roles of reticulum cell sarcoma and normal lymphoid cells in lymphokine production. (1984) (9)
The synthesis and actions of mouse and human interferons in mouse-human hybrid cells. (1978) (9)
Selection of new human foreskin fibroblast cell strains for interferon production. (1978) (9)
Effect of rabbit interferon on immune responses. (1974) (9)
Interferon research BC (before cloning). (2007) (8)
Morphogenesis of rabbit fibroma virus. Correlation with pathogenesis of the skin lesion. (1971) (8)
Stimulation of lymphokine production by teleocidin, aplysiatoxin, and debromoaplysiatoxin. (1983) (8)
A prize for the foreign‐born (2006) (8)
Mycobacterium bovis infection of mice lacking receptors for interferon-gamma or for transcription factor IRF-1. (1994) (8)
Transcriptional basis for the differences in inducible nitric oxide synthase (iNOS) expression between nonmetastatic and metastatic murine melanoma cell lines. (1999) (8)
Studies on an interferon from tickborne encephalitis virus-infected cells (IF). II. Physical and chemical properties of IF. (1961) (8)
Accessory function of thymic and tonsillar dendritic cells in interferon gamma production by T lymphocytes. (1986) (7)
Assay of the tick-borne encephalitis virus in HeLa cells. I. Cytopathic effect and metabolic inhibition. (1960) (7)
Synthesis and biological characterization of a covalent conjugate between interferon and ricin toxin B chain. (1982) (7)
Regulation of interferon production: cell culture studies. (1977) (7)
CCAAT box enhancer binding protein alpha (C/EBP-alpha) stimulates kappaB element-mediated transcription in transfected cells. (1996) (7)
Foreign minds, fenceless imagination: The 2013 Vilcek Foundation Prizes (2013) (6)
Cytokines in 1995. (1996) (6)
CONCENTRATION AND PARTIAL PURIFICATION OF INTERFERON FROM MOUSE BRAINS. (1964) (6)
Interference between tick-borne enceohalitis and Western equine encephalomyelitis viruses in chick embryo tiseue cultures. (1960) (6)
Immunologically specific production of interferon in cultures of rabbit blood lymphocytes: association with in vitro tests for cell-mediated immunity (1975) (6)
THE ROLE OF INTERFERON IN TICK-BORNE ENCEPHALITIS VIRUS-INFECTED L CELLS. II. PERSISTENT INFECTION. (1965) (6)
THE ROLE OF INTERFERON IN TICK-BORNE ENCEPHALITIS VIRUS-INFECTED L CELLS. I. ACUTE INFECTION. (1965) (6)
Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilis. (1992) (5)
Le interferon mRNA from human fibroblasts. (1980) (5)
Protodyne: an immunomodulatory protein component, prepared from bacillus subtilis (1991) (5)
Production of human fibroblast interferon in the presence of the glycosylation inhibitor tunicamycin. (1981) (5)
A simple neutralization test for viruses of the tick-borne encephalitis group, depending on a complete cytopathic effect in HeLa cells. (Preliminary report). (1959) (5)
The cytokinesAn overview (2003) (5)
TSG-6: A Novel Secretory Protein Inducible by Tumor Necrosis Factor or Interleukin-1 in Fibroblasts and Mononuclear Cells (1993) (5)
Interaction of interferon with chick embryo cells (2005) (5)
Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis. (1982) (4)
Why are rabbits uniquely sensitive to myxoma virus? Cherchez l'interferon! (2004) (4)
An investigation into the mechanism of cytotoxicity of levorphanol. (1971) (4)
Biological Functions of IFN-γand IFN-α/β : Lessons from Studies in Gene Knockout Mice (Nagano Symposium 7) (1994) (4)
The Uptake of a Labeled Double-Stranded Polynucleotide by Cultured Rabbit Kidney Cells: An Electron Microscopic Study (1970) (4)
Interferon-gamma enhances target cell sensitivity to monocyte killing. (1986) (4)
Mechanisms and significance of the mitogenic and antiviral actions of TNF. (1988) (4)
Cytokines as therapeutics and targets of therapeutics (2006) (3)
ALPHA INTERFERON AND ANTIBODY TO ALPHA INTERFERON IN SYSTEMIC LUPUS ERYTHEMATOSUS (1982) (3)
My fifty years with interferon. (2007) (3)
Gems from Distant Shores The 2012 Vilcek Foundation Prizes (2012) (3)
Forty years of interferon, forty years of cytokines. (1997) (3)
Coproduction of interleukin-2 and interferon-gamma in human mononuclear cells. (1983) (3)
Antibodies to chromosome 21 coded cell surface components block binding of human alpha interferon but not gamma interferon to human cells. (1984) (3)
Studies on an Interferon from Tick-Borne Encephalitis Virus-Infected Cells. V. Failure of Thermally Inactivated Virus to induce or to influence Interferon Formation. (1963) (3)
Temperature-sensitive interferon production in rabbit kidney cell cultures treated with toyocamycin. (1973) (3)
STRUCTURE-FUNCTION STUDIES WITH HUMAN INTERFERON-GAMMA (1982) (3)
Incidence of antibodies against tick-borne encephalitis virus in man and domestic animals in a small village in a natural focus of infection. (1960) (2)
Interferon as a cell product. (1979) (2)
There is more to hemorrhagic necrosis than tumor necrosis factor. (1991) (2)
The clinical potential of interferons : treatment of viral diseases and malignant tumors : proceedings of the International Conference on Clinical Potentials of Interferons in Viral Diseases and Malignant Tumors, held December 2-4, 1980 (1982) (2)
Knockouts of Interferons, Interferon Receptors and Interferon Signaling Components (1998) (2)
[15] Production of rabbit interferon (1981) (2)
Induction of human interferon gamma with phorbol esters and phytohemagglutinin. (1986) (2)
Cytokines: Wherefrom and Whereto (2005) (2)
Some aspects of the use of a transformed line of human amniotic cells in virological work. (1959) (2)
Production of rabbit interferon. (1981) (2)
Inhibition of Growth of Bi 6 Murine Malignant Melanomaby Exogenous Interferon (1980) (2)
Profile of Angelika Amon, winner of the 2019 Vilcek Prize in Biomedical Science (2019) (1)
“America First” Will Destroy U.S. Science (2020) (1)
Inverse interference by growth factors. (1987) (1)
Recent progress in the elucidation of interferon alfa/beta and interferon gamma actions. (1993) (1)
Monoclonal and chimeric antibodies that are specific for human tumor necrosis factor (1992) (1)
Interferon induction with Newcastle disease virus in FS-4 cells: Effect of 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) (2005) (1)
Suppression oftheIntracellular GrowthofShigella flexneri inCell Cultures byInterferon Preparations andPolyinosinic-Pol ycytidylic (1972) (1)
Stimulation of gamma interferon production by TPA and related diterpene esters. (1981) (1)
From Snail Brains to Art History: Reductionism in Art and Brain Science: Bridging the Two Cultures: by Eric R. Kandel: Columbia University Press, New York, 2016. (2017) (1)
SUPPRESSION OF ANTIGEN‐INDUCED INTERFERON SYNTHESIS IN HUMAN LYMPHOCYTES BY COTTON‐ADHERENT MONONUCLEAR CELLS * (1980) (1)
Reassessing the Usual Suspects Causing a Commotion in the Blood (and Vessels?) (2004) (1)
HOW MANY INTERFERONS ARE THERE (1981) (1)
Ir gene restricted induction by lymph node t cells of lymphokine synthesis in irradiated lymphoma cells of sjl j mice (1982) (1)
USE OF INTERFERENCE FOR THE ASSAY OF GROUP B ARBOVIRUSES IN CHICK EMBRYO CELLS. (1964) (1)
Studies on the enhancement of interferon production in human diploid (FS-4) cells by ultraviolet. (1978) (1)
Synergistic Actions of Interferons and Tumor Necrosis Factor (1988) (1)
Interferon Popularized: Interferons . A Primer. Robert M. Friedman. Academic Press, New York, 1981. xii. 152 pp., illus. $17.50. (1981) (0)
Analysis of interferon type I receptor activation using cytokine receptor chimeras (2001) (0)
Le INTERFERON PRODUCTION BY HUMAN FIBROBLASTS (1980) (0)
Studies with purified human gamma interferon (1982) (0)
Vigorous Vitamins (1975) (0)
United States Patent ( 19 ) Guegler et al . 54 POLYNUCLEOTDE ENCODING NOVEL CHEMOKNE EXPRESSED IN NFLAMED ADENOD ( 75 ) Inventors : (2017) (0)
Regulation of Cell Growth by Interferon and Tumor Necrosis Factor (1987) (0)
First rounders: Jan Vilcek (2017) (0)
DISCUSSION (1970) (0)
K. F. Meyer (1974) (0)
Generation and Characterization of Human T-Cell Hybridomas That Constitutively Produce Immune Interferon (1985) (0)
Regulation of Human Fibroblast Growth by Autocrine Interferon-Beta (1987) (0)
333 Echocardiography Reporting in Ischaemic Heart Disease and Compliance With European Association Cardiovascular Imaging (EACVI) Recommendations (2020) (0)
Mono clonal antibodies directed against t cell antigens induce interferon gamma synthesis in human thymocytes and t lymphocytes (1983) (0)
Profile of Alexander Y. Rudensky, winner of the 2018 Vilcek Prize in Biomedical Science (2018) (0)
[Incidence & method of detection of adenoviruses]. (1959) (0)
Interferon Popularized. (Book Reviews: Interferons) (1981) (0)
Specific anti-human tumor necrosis factor monoclonal and chimeric antibodies (1992) (0)
All About Interferon (1973) (0)
Control of Inducible Nitric Oxide Synthase Gene Expression by Interferon Regulatory Factor-1: Implications for Host Resistance to Bacteria and Viruses (1996) (0)
Lymphokine synthesis in irradiated lymphoma cells of sjl/j mice. Abstr. (1982) (0)
K. F. Meyer. In memoriam. (1974) (0)
For human tumor necrosis factor-specific monoclonal and chimeric antibodies (1992) (0)
Profile of Xiaowei Zhuang, winner of the 2020 Vilcek Prize in Biomedical Science (2020) (0)
Profile of Dan Littman, winner of the 2016 Vilcek Prize in Biomedical Science (2016) (0)
Introduction: Importance of oestrogen, xenoestrogen and phytoestrogen metabolism in breast cancer risk? (2009) (0)
Cytokine-induced protein, tsg-6, his dna and use (1992) (0)
TSG-6: A Hyaladherin Associated with Inflammation (1999) (0)
specific monoclonal antibodies and chimeric factor for human tumor necrosis. (1992) (0)
Assay of the Tick-Borne Encephalitis Virus in HeLa Cells. II. Neutralisation Tests using the Cytopathic and Metabolic Inhibition Effects. (1961) (0)
Are specific for human tumor necrosis factor-related monoclonal and chimeric antibodies (1992) (0)
Induction and Characterization of Human Immune (Gamma) Interferon (1982) (0)
Phase Ib of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanoma (1994) (0)
Love, Science, and Autoimmune Therapy (2017) (0)
Contents, Vol. 104, 1994 (1994) (0)
Cell substrates for biologicals other than vaccines. Introductory remarks. (1979) (0)
Production of human alpha- and beta- interferons by human-rodent hybrids. (1982) (0)
Growth factors as interferon inducers and interferon inducers as growth factors (1986) (0)
OF ENHANCING THE PRODUCTION OF HUMANy INTERFERON 75 Inventors : (2017) (0)
Proceedings of a symposium on interferon. (1970) (0)
Dns and these containing recombinant plasmid. (1983) (0)
INDUCTION OF HUMAN LYMPHOCYTE ANTIGEN CLASS I mRNA IN HUMAN FIBROBLASTS BY CYTOKINES (1993) (0)
Interfering with cancer (1975) (0)
Altered cellular responses to interferon induction by poly I · poly C: Priming and hyporesponsiveness in cells treated with interferon preparations (2005) (0)
Pharmacokinetic Properties ofHumanFibroblast and Leukocyte Interferon inRabbits (1980) (0)
Profile of Lily and Yuh Nung Jan, winners of the 2017 Vilcek Prize in Biomedical Science (2017) (0)
Antiviral Action of TNF in Human Fibroblasts Requires the Presence of Subeffective Concentrations of Classical Interferon‐β a (1989) (0)
Inhibition of interferon production in human fibroblasts by a tumor promoting phorbol ester (2005) (0)
[THE PROCESS OF MULTIPLICATION OF TICK ENCEPHALITIS VIRUSES IN SENSITIVE CELLS]. (1963) (0)
Interferon Synthesis Post-Transcriptional Control of (2014) (0)
Distribution of neutralizing antibodies against leukocyte and fibroblast interferons in rabbits immunized with leukocyte orfibroblast interferons (0)
Temperature-sensitive interferon production in rabbit kidney cell cultures treated with toyocamycin. (1973) (0)
Human and murine cellular models for caspase independent death induced by TNF or dsRNA (2001) (0)
Partial purification and characterization of human y ( immune ) interferon ( 12-0-tetradecanoylphorbol 13-acetate / phytohemagglutinin / concanavalin A-Sepharose / molecular-sieve chromatography / isoelectric focusing ) (0)
The Clinical Potential of Interferon: Treatment of Viral Diseases and Malignant Tumors (Japan Medical Research Foundation (1984) (0)
OPENING REMARKS (1980) (0)
Analogifremgangsmaade for the production of interferon gamma polypeptide, a DNA sequence coding therefor, plasmid containing DNA sequence and a microorganism containing the plasmid (1983) (0)
Monoclonal antibodies against human tumor necrosis factor and chimeric (1992) (0)
Joseph A. Sonnabend (1933-2021): Pioneering Interferon Researcher Turned AIDS Activist. (2021) (0)
The Long Road To Renown: The 2015 Vilcek Foundation Prizes (2015) (0)

This paper list is powered by the following services:

Other Resources About Jan Vilček

What Schools Are Affiliated With Jan Vilček?

Jan Vilček is affiliated with the following schools:

Jan Vilček's Academic­Influence.com Rankings